KraneShares MSCI All China Health Care Index ETF (KURE) Fund Overview

KraneShares MSCI All China Health Care Index ETF (KURE) Financial Services Profile

KraneShares MSCI All China Health Care Index ETF (KURE) provides targeted exposure to the Chinese healthcare sector, tracking an index of free float adjusted market capitalization weighted companies. With a beta of 0.59 and assets under management of $0.08 billion, KURE offers investors a focused investment vehicle within the Chinese equity market.

What Is the Investment Thesis for KURE?

KURE presents a focused investment opportunity in the Chinese healthcare sector, driven by the increasing demand for healthcare services in China. The fund's strategy of mirroring the MSCI All China Health Care Index provides targeted exposure to this growth. Key value drivers include the expansion of China's healthcare infrastructure and increasing healthcare spending. Potential catalysts include regulatory reforms favoring the healthcare sector and advancements in medical technology within China. However, investors may want to evaluate risks such as regulatory changes, geopolitical tensions, and market volatility affecting Chinese equities. With a beta of 0.59, KURE exhibits lower volatility compared to the broader market.

Based on FMP financials and quantitative analysis

KURE Key Highlights

The fund invests at least 80% of its net assets in instruments in its underlying index.

• The underlying index is a free float adjusted market capitalization weighted index.
• The fund is designed to measure the equity market performance of Chinese companies in the healthcare sector.
• The fund is non-diversified.
• The fund has a beta of 0.59, indicating lower volatility compared to the market.

Who Are KURE's Competitors?

KURE is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are KURE's Key Strengths?

Targeted exposure to the Chinese healthcare sector.

• Replication of a well-known index (MSCI All China Health Care Index).
• Established brand recognition as a KraneShares ETF.
• Relatively low beta of 0.59.

What Are KURE's Weaknesses?

Non-diversified nature increases risk.

• Concentration in a single country (China) exposes it to geopolitical risks.
• Dependence on the performance of the Chinese healthcare sector.
• Small market cap of $0.08B may limit liquidity.

What Are the Key Risks for KURE?

Rich valuation — a P/E of 22.68 runs well above the Financial Services sector’s ~17.20x, leaving little room for a miss.

• Regulatory changes in China affecting the healthcare sector.
• Geopolitical tensions between China and other countries.
• Economic slowdown in China.
• Competition from other ETFs and investment funds.

What Are KURE's Competitive Advantages?

• Specialized focus on the Chinese healthcare sector.
• Replication of the MSCI All China Health Care Index.
• Established track record in the Chinese equity market.
• Brand recognition as a KraneShares ETF.

What Does KURE Do?

KraneShares MSCI All China Health Care Index ETF (KURE) is designed to provide investors with exposure to the healthcare sector within the Chinese equity market. The fund operates by investing at least 80% of its net assets, plus borrowings for investment purposes, in instruments that mirror its underlying index or possess similar economic characteristics. This underlying index is meticulously constructed as a free float adjusted market capitalization weighted index, adhering to the 10/40 Constraint, which is a diversification rule limiting the weight of any single component. KURE's primary objective is to closely track the equity market performance of Chinese companies operating in the healthcare sector, offering a focused investment tool for those seeking to capitalize on the growth and potential of China's healthcare industry. The fund is non-diversified, meaning it invests a larger percentage of its assets in a smaller number of issuers compared to a diversified fund.

What Products and Services Does KURE Offer?

• Invests in a portfolio of Chinese healthcare companies.
• Tracks the MSCI All China Health Care Index.
• Provides exposure to the Chinese healthcare sector.
• Offers a focused investment vehicle for Chinese equities.
• Replicates the performance of the underlying index.
• Operates as a non-diversified fund.

How Does KURE Make Money?

• Generates revenue through management fees.
• Invests in Chinese healthcare companies.
• Tracks the MSCI All China Health Care Index.
• Provides a vehicle for investors to access the Chinese healthcare market.

What Industry Does KURE Operate In?

KURE operates within the asset management industry, specifically focusing on providing access to the Chinese healthcare sector. The global asset management industry is experiencing growth, driven by increasing demand for specialized investment products. The Chinese healthcare market is expanding due to factors such as an aging population and rising income levels. KURE competes with other ETFs and investment funds offering exposure to Chinese equities and the healthcare sector. Competitors include funds with broader mandates or different weighting methodologies.

Who Are KURE's Key Customers?

• Institutional investors seeking exposure to Chinese healthcare.
• Retail investors interested in the Chinese equity market.
• Financial advisors looking for specialized investment products.
• Pension funds and endowments seeking diversification.

KURE Financials

KURE Latest News

KURE Analyst Consensus

KURE MoonshotScore

What Investors Ask About KraneShares MSCI All China Health Care Index ETF (KURE) — Financials

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources